2000
DOI: 10.1002/1099-081x(200005)21:4<121::aid-bdd216>3.0.co;2-y
|View full text |Cite
|
Sign up to set email alerts
|

Influence of acebutolol and metoprolol on cardiac output and regional blood flow in rats

Abstract: Beta-adrenoceptor blocking drugs are widely used as effective antihypertensive and antianginal agents. We have determined the effect of beta-blockade in the rat to ascertain whether there are differences between metoprolol (MET) and acebutolol (AC) with respect to regional blood flow (RBF). Both AC and MET were administered as a single or multiple intravenous (iv) doses in Sprague-Dawley rats. Microspheres labelled with (85)Sr and (141)Ce were used to measure cardiac output (CO) and RBF before and after drug a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2003
2003
2014
2014

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 31 publications
1
1
0
Order By: Relevance
“…There was no significant difference in hepatic arterial and portal blood flow between rats with and without the ileal and hepatic portal vein catheterizations. These blood flow values are in the range of those reported by others (23,24,29,34,46). Furthermore, hepatic portal blood flow increased in response to intraduodenal glucose infusion at increments that were similar between rats with and without the ileal and hepatic portal vein catheterizations.…”
Section: Resultssupporting
confidence: 84%
“…There was no significant difference in hepatic arterial and portal blood flow between rats with and without the ileal and hepatic portal vein catheterizations. These blood flow values are in the range of those reported by others (23,24,29,34,46). Furthermore, hepatic portal blood flow increased in response to intraduodenal glucose infusion at increments that were similar between rats with and without the ileal and hepatic portal vein catheterizations.…”
Section: Resultssupporting
confidence: 84%
“…Radiopharmaceuticals based on selective β 1 ‐AR are expected to show high heart uptake . Acebutolol (Figure ) is a chiral β 1 ‐AR blocking agent . The aim of the present approach is to build up simple and efficient method for radioiodination of acebutolol by studying the factors that will affect radioiodination process in details and to evaluate biologically the radioiodinated acebutolol as a radiotracer for MPI.…”
Section: Introductionmentioning
confidence: 99%